PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 62 filers reported holding PLIANT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,630,012 | +2.5% | 94,003 | +7.2% | 0.00% | – |
Q2 2023 | $1,589,540 | -79.1% | 87,723 | -69.3% | 0.00% | -100.0% |
Q1 2023 | $7,593,342 | +244.6% | 285,464 | +150.5% | 0.00% | – |
Q4 2022 | $2,203,233 | -50.6% | 113,980 | -46.7% | 0.00% | -100.0% |
Q3 2022 | $4,464,000 | +56.6% | 213,693 | -40.0% | 0.00% | – |
Q2 2022 | $2,850,000 | +26.0% | 356,039 | +10.3% | 0.00% | – |
Q1 2022 | $2,262,000 | -51.2% | 322,764 | -5.9% | 0.00% | -100.0% |
Q4 2021 | $4,632,000 | +81.4% | 343,120 | +126.9% | 0.00% | – |
Q3 2021 | $2,554,000 | +160.1% | 151,245 | +348.9% | 0.00% | – |
Q2 2021 | $982,000 | +477.6% | 33,695 | +679.4% | 0.00% | – |
Q1 2021 | $170,000 | -22.0% | 4,323 | -55.0% | 0.00% | – |
Q4 2020 | $218,000 | -40.8% | 9,607 | -40.9% | 0.00% | – |
Q3 2020 | $368,000 | +569.1% | 16,256 | +856.2% | 0.00% | – |
Q2 2020 | $55,000 | – | 1,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |